DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Lupin - 4 Ramesh Swaminathan - 3 Lupin Ramesh Swaminathan - 1
Top related locs:
China India Australia
Top related orgs:
Medicine - 1 EU - 1

Search resuls for: "Ramesh Swaminathan"


5 mentions found


☆ Lupin Global CFO: Medicine business benefitting from supply chain diversification
  + stars: | 2024-11-08 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailLupin Global CFO: Medicine business benefitting from supply chain diversificationRamesh Swaminathan, Global CFO of Lupin discusses the impact of Trump's win on the Indian pharmaceutical sector. Growing demand for affordable medicines, and diversification from China are key factors benefitting his company. He also talks about R&D and productivity as drivers to further increase margins.
Persons: Ramesh Swaminathan, Lupin Organizations: Medicine Locations: China
☆ The U.S. and India remain our most important markets: Indian pharmaceutical company Lupin
  + stars: | 2024-05-07 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThe U.S. and India remain our most important markets: Indian pharmaceutical company LupinRamesh Swaminathan, global CFO and executive director of Lupin, discusses the company's earnings report.
Persons: Lupin Ramesh Swaminathan, Lupin Locations: India
☆ We're in for a period of secular growth, says Indian pharmaceutical firm
  + stars: | 2024-02-08 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWe're in for a period of secular growth, says Indian pharmaceutical firmRamesh Swaminathan of Lupin discusses its product pipeline and U.S. sales forecast.
Persons: Ramesh Swaminathan, Lupin
☆ There's been secular growth across all our markets, says Indian pharmaceutical company
  + stars: | 2023-08-04 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThere's been secular growth across all our markets, says Indian pharmaceutical companyRamesh Swaminathan of Lupin says there was growth in markets such as the EU and Australia.
Persons: Ramesh Swaminathan, Lupin Organizations: EU Locations: Australia
☆ Secular inflation has run across industries and we aren't immune, says pharmaceutical company
  + stars: | 2023-05-10 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailSecular inflation has run across industries and we aren't immune, says pharmaceutical companyRamesh Swaminathan of Lupin discusses the company's quarterly results and says "gross margins could have been better but for this inflation factor."
0 next >>
Total: 5